当前位置: 首页 >> 检索结果
4797. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
作者: Keith Humphreys.;Chelsea L Shover.;Christina M Andrews.;Amy S B Bohnert.;Margaret L Brandeau.;Jonathan P Caulkins.;Jonathan H Chen.;Mariano-Florentino Cuéllar.;Yasmin L Hurd.;David N Juurlink.;Howard K Koh.;Erin E Krebs.;Anna Lembke.;Sean C Mackey.;Lisa Larrimore Ouellette.;Brian Suffoletto.;Christine Timko.
来源: Lancet. 2022年399卷10324期555-604页 4799. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
作者: Sanjiv J Shah.;Barry A Borlaug.;Eugene S Chung.;Donald E Cutlip.;Philippe Debonnaire.;Peter S Fail.;Qi Gao.;Gerd Hasenfuß.;Rami Kahwash.;David M Kaye.;Sheldon E Litwin.;Philipp Lurz.;Joseph M Massaro.;Rajeev C Mohan.;Mark J Ricciardi.;Scott D Solomon.;Aaron L Sverdlov.;Vijendra Swarup.;Dirk J van Veldhuisen.;Sebastian Winkler.;Martin B Leon.; .
来源: Lancet. 2022年399卷10330期1130-1140页
Placement of an interatrial shunt device reduces pulmonary capillary wedge pressure during exercise in patients with heart failure and preserved or mildly reduced ejection fraction. We aimed to investigate whether an interatrial shunt can reduce heart failure events or improve health status in these patients.
4800. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
National rates of COVID-19 infection and fatality have varied dramatically since the onset of the pandemic. Understanding the conditions associated with this cross-country variation is essential to guiding investment in more effective preparedness and response for future pandemics.
|